20 February 2019

INFANT Irish Centre for Fetal and Neonatal Translational Research

2018

Commitment Progress

INFANT has continued to deliver on its commitment to fund a PhD student from Zimbabwe to come to the INFANT centre for four years (Q1 2016-Q4 2019) to conduct research in the area of pre-eclampsia. This commitment represents an investment in knowledge exchange and capacity building which will, ultimately, contribute to strengthening of the health system in Zimbabwe. This represents a financial commitment of €95,000 (€23,770 per year for four years). INFANT has already committed over 3 years of funding to this commitment.
IINFANT continued to dedicat at least one of its fortnightly Research Seminars each year from 2016 up to 2019, to presenting and discussing progress towards delivering on our commitments to the new Global Strategy. This is increasing awareness in our research teams of the global need and the global challenges in meeting these needs and therefore ensure that INFANT technology is produced fit for purpose in LMICs where the clinical need is greatest.

INFANT has established a Memorandum of Understanding with the Good Samaritan Foundation in Moshi, Tanzania in 2016 with a view to cooperating on a number of research domains. The intention is that, ultimately, the partnership will: • Facilitate knowledge exchange for our engineers and scientists who will gain first-hand practical experience of the challenges of translating cutting edge devices and diagnostics into low fidelity clinical arenas. • Offer mutual education and training opportunities in an array of multidisciplinary areas pertinent to maternal and neonatal health. • Build capacity in areas where skilled human resources are scarce. • Allow robust, well designed collaborative trials in geographical areas and patient populations where the need for intervention is greatest. INFANT has continued to make progress towards its commitment that by 2030, we will fulfil lour research commitment to the Global Strategy for Women’s and Children’s Health by working with our industry partners to translate our research into affordable, accessible and robust interventions that will reduce dependence on expensive technology and scarce, highly trained human resources, and thus provide affordable technology based solutions for unmet clinical needs.

INFANT has commited significant resources over 2018, both financial and human resources, to upgrading the KCMC Nothern Tanzania Birth Registry and also helping to upgrade and support neonatal intensive care at KCMC zonal/referral hospital.

2017

Commitment Progress

INFANT has delivered on its commitment to  fund a PhD student from Zimbabwe to come to the INFANT centre for four years (Q1 2016-Q4 2019) to conduct research in the area of pre-eclampsia. This commitment represents an investment in knowledge exchange and capacity building which will, ultimately, contribute to strengthening of the health system in Zimbabwe. This represents a financial commitment of €95,000 (€23,770 per year for four years). INFANT has already committed over 2 years of funding to this commitment.

INFANT will dedicate one of its fortnightly Research Seminars each year from 2016 up to 2019, to presenting and discussing   progress towards delivering on our commitments to the new Global Strategy. This will increase awareness in our research teams of the global need and the global challenges in meeting these needs and therefore ensure that INFANT technology is produced fit for purpose in LMICs where the clinical need is greatest.

INFANT has dedicated  at least one of its fortnightly Research Seminars each year from 2016 up to 2019, to presenting and discussing   progress towards delivering on our commitments to the new Global Strategy. This is increasing awareness in our research teams of the global need and the global challenges in meeting these needs and therefore ensure that INFANT technology is produced fit for purpose in LMICs where the clinical need is greatest.

INFANT has established a Memorandum of Understanding with the Good Samaritan Foundation in Moshi, Tanzania in 2016 with a view to cooperating on a number of research domains.
The intention is that, ultimately, the partnership will:
• Facilitate knowledge exchange for our engineers and scientists who will gain first-hand practical experience of the challenges of translating cutting edge devices and diagnostics into low fidelity clinical arenas.
• Offer mutual education and training opportunities in an array of multidisciplinary areas pertinent to maternal and neonatal health.
• Build capacity in areas where skilled human resources are scarce.
• Allow robust, well designed collaborative trials in geographical areas and patient populations where the need for intervention is greatest.
INFANT has continued to make progress towards its commitment that by  2030, we will  fulfill our  research commitment to the Global Strategy for Women’s and Children’s Health by working with our industry partners to translate our research into affordable, accessible and robust interventions that will reduce dependence on expensive technology and  scarce, highly trained human resources, and thus provide affordable technology based solutions for unmet clinical needs.

2015

INFANT (the Irish Centre for Fetal and Neonatal Translational Research) commits to support the implementation of the Global Strategy for Women’s, Children’s and Adolescents’ Health (2016-2030) by continuing to advance our research and innovation in perinatal healthcare, thereby addressing the most common complications of pregnancy and most significant problems for newborn babies. INFANT recognizes that maternal and perinatal complications, which account for almost 10% of the global burden of disease, are disproportionately experienced in developing countries. INFANT will help to address this inequality through pioneering innovation in next generation devices that will transform antenatal and neonatal healthcare and service delivery.

INFANT is committed to translating our innovations into affordable, accessible and robust interventions (such as a chip-based screening test in early pregnancy for pre-eclampsia) that will reduce dependence on expensive technology and scarce human resources and expertise. This will have greatest impact in low resource settings where the burden of disease is highest. INFANT has made specific commitments for the next four years, including funding equipment for neonatal seizure detection and treatment in a low resource setting and will directly fund the doctoral research on pre-eclampsia of a low-income country researcher, thus promoting knowledge exchange and capacity building.

Commitment Progress

INFANT remains on track to fulfill its longer term commitments to advancing the goals for the Global Strategy for Women’s, Children’s and Adolescents’ Health. Over 2016 , we have made progress in translating our innovations into affordable, accessible and robust interventions (such as a chip-based screening test in early pregnancy for pre-eclampsia, and neonatal seizure detection in low resource settings) that will reduce dependence on expensive technology and scarce human resources and expertise. We have made progress on a range of translational projects in the following areas with a view of deploying innovations to clinical use in the medium term – pregnancy, birth, newborn health, child health, mother’s health post pregnancy. We have also established a formal collaborative research partnership with the Kilimanjaro Clinical Research Institute in Moshi, Tanzania with a view to:

  • Facilitate knowledge exchange for our engineers and scientists who will gain first-hand practical experience of the challenges of translating cutting edge devices and diagnostics into low fidelity clinical arenas.
  • Offer education and training opportunities for Tanzanian researchers in an array of multidisciplinary areas pertinent to maternal and neonatal health.
  • Build capacity in areas where skilled human resources are scarce.
  • Allow robust, well designed collaborative trials in geographical areas and patient populations where the need for intervention is greatest.

Furthermore,  we have secured further funding (Wellcome Trust Seed Award) to develop a portable low-cost newborn brain ‘stethoscope’ which can assess brain health immediately after birth. INFANT has made progress on its specific commitments for the next four years, including supervising and funding the doctoral research (on pre-eclampisa) of a low-income country researcher.
CLEAR-infant-logo300x113